Durvalumab immunotherapy recommended for advanced bile duct cancers in England and Scotland – Cancer Research UK
NICE and the SMC made their selections after consulting the outcomes of the Part III TOPAZ-1 trial, which confirmed that ...
Tag: Durvalumab